You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
The companies are joining BioView's Duet imaging system with Ruby Nanomed's Rubychip microfluidic device for circulating tumor cell isolation.
The firm is planning to use its platform to offer a spatial gene expression analysis service early next year, with other analytes to follow.
The Stanford University spinout cofounded by Euan Ashley will use the funding to develop its microfluidics-based cell sorting and analysis technology.
Illumina Ventures led the round for the Santa Clara, California-based firm, which is developing applications for its optical detection technology.
In Genome Research this week: unrecognized spread of SARS-CoV-2 in New York last February, assay of cell line responses to drug treatment, and more.
In PNAS this week: similar muscle protein patterns across hypertrophic cardiomyopathy phenotypes, analysis of gene expression and brain anatomy in major depression, and more.
In Nature this week: a suite of papers describing functional elements within the genome, and more.
The companies hope to combine their technologies to provide pharmaceutical customers with an end-to-end workflow for multiplex histological staining and imaging.
New Scientist reports that researchers have found a quadruple-stranded form of DNA within healthy human cells.
In Nature this week: CRISPR approaches to editing plant genomes, way to speed up DNA-PAINT, and more.
The Wall Street Journal reports on gaps in COVID-19 testing affecting less affluent urban areas and rural locations.
According to NBC News, new SARS-CoV-2 variants are making it harder for researchers to model the course of the pandemic.
The New York Times reports that experts say President Joe Biden's goal of vaccinating 1 million people a day in the US in the next 100 days is too low a bar.
In Science this week: single-cell lineage tracing technique applied to study lung cancer metastasis, and more.